Form 4 for MRNA Moderna
Accepted 2022-03-25 00:00:00 ET · period of report 2022-03-23 · accession 0001127602-22-010393 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-25 | 2022-03-23 | MRNA | Andres Juan | See remarks | S - Sale+OE | $184.66 | -2,000 | 9,069 | -18% | -$369.3K |
| D | 2022-03-25 | 2022-03-23 | MRNA | Andres Juan | See remarks | M - OptEx | $14.22 | +2,000 | 11.1K | +22% | +$28.4K |
| D | 2022-03-25 | 2022-03-23 | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -2,000 | 12.6K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-23 | S | D | 2,000 | $184.66 | 9,069 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-23 | M | A | 2,000 | $14.22 | 11,069 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-23 | M | D | 2,000 | $0.00 | 12,629 | D | $14.22 · — to 2028-02-28 | 2,000 Common Stock | (F2) This option is fully vested and exercisable. |